17,024 Pediatrix Medical Group, Inc. $MD Shares Purchased by Ritholtz Wealth Management

Ritholtz Wealth Management raised its stake in shares of Pediatrix Medical Group, Inc. (NYSE:MD) by 9.0% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 206,455 shares of the company’s stock after buying an additional 17,024 shares during the period. Ritholtz Wealth Management’s holdings in Pediatrix Medical Group were worth $5,312,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently made changes to their positions in the stock. Choreo LLC lifted its position in shares of Pediatrix Medical Group by 5.7% in the third quarter. Choreo LLC now owns 8,361 shares of the company’s stock worth $215,000 after buying an additional 448 shares during the last quarter. Nisa Investment Advisors LLC increased its holdings in shares of Pediatrix Medical Group by 3.3% during the 3rd quarter. Nisa Investment Advisors LLC now owns 19,131 shares of the company’s stock valued at $492,000 after acquiring an additional 605 shares during the last quarter. Hohimer Wealth Management LLC increased its holdings in shares of Pediatrix Medical Group by 5.4% during the 3rd quarter. Hohimer Wealth Management LLC now owns 12,714 shares of the company’s stock valued at $327,000 after acquiring an additional 655 shares during the last quarter. State of Wyoming raised its stake in shares of Pediatrix Medical Group by 4.5% in the 3rd quarter. State of Wyoming now owns 24,525 shares of the company’s stock valued at $631,000 after acquiring an additional 1,060 shares in the last quarter. Finally, Concurrent Investment Advisors LLC raised its stake in shares of Pediatrix Medical Group by 4.0% in the 2nd quarter. Concurrent Investment Advisors LLC now owns 28,384 shares of the company’s stock valued at $719,000 after acquiring an additional 1,087 shares in the last quarter. Institutional investors and hedge funds own 97.71% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities research analysts recently weighed in on the company. Weiss Ratings upgraded Pediatrix Medical Group from a “hold (c+)” rating to a “buy (b-)” rating in a report on Wednesday, September 9th. Mizuho downgraded Pediatrix Medical Group from a “neutral” rating to an “underperform” rating and set a $28.00 price target on the stock. in a report on Wednesday. Truist Financial increased their price target on Pediatrix Medical Group from $28.00 to $31.00 and gave the company a “hold” rating in a report on Friday, October 30th. Jefferies Financial Group lowered shares of Pediatrix Medical Group from a “buy” rating to a “hold” rating and lifted their price target for the company from $27.00 to $28.00 in a research report on Wednesday, August 19th. Finally, UBS Group boosted their price objective on shares of Pediatrix Medical Group from $25.00 to $28.00 and gave the stock a “neutral” rating in a research note on Thursday, August 6th. One investment analyst has rated the stock with a Buy rating, five have issued a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, Pediatrix Medical Group has a consensus rating of “Hold” and a consensus price target of $28.00.

Pediatrix Medical Group Price Performance

Shares of NYSE:MD opened at $31.39 on Friday. The business has a 50 day moving average price of $27.79 and a 200 day moving average price of $24.29. Pediatrix Medical Group, Inc. has a twelve month low of $17.23 and a twelve month high of $33.74. The company has a market cap of $2.45 billion, a price-to-earnings ratio of 17.06 and a beta of 0.62. The company has a quick ratio of 1.28, a current ratio of 1.28 and a debt-to-equity ratio of 0.47.

Pediatrix Medical Group (NYSE:MD) last released its earnings results on Thursday, October 29th. The company reported $0.72 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.65 by $0.07. The firm had revenue of $501.37 million for the quarter, compared to analyst estimates of $498.18 million. Pediatrix Medical Group had a return on equity of 20.12% and a net margin of 7.66%. The company’s revenue was up 1.7% on a year-over-year basis. During the same quarter last year, the firm posted $0.67 EPS. Research analysts predict that Pediatrix Medical Group, Inc. will post 2.21 earnings per share for the current year.

Pediatrix Medical Group Profile

Pediatrix Medical Group provides physician services to hospitals and other healthcare facilities across the United States. Its clinicians care for women, newborns and children, working with healthcare partners to support patients in hospital and other clinical settings. The company’s services include neonatal care, maternal-fetal medicine and pediatric subspecialties. Its physicians and advanced practice providers deliver care such as treatment for high-risk pregnancies and specialized medical services for newborns and children.